Calidi Biotherapeutics, Inc. Grants Receivable
Calidi Biotherapeutics, Inc. (CLDI) had Grants Receivable of $50.00 thousand as of 2025-06-30, per its 10-Q filed 2025-08-08.
Financial Statements › Notes › Nontrade Receivables
us-gaap:GrantsReceivable · last filed 2025-08-08
- 2025-06-30: Grants Receivable $50.00K.
- 2025-03-31: Grants Receivable $50.00K.
- 2024-06-30: Grants Receivable $181.00K.
- 2023-12-31: Grants Receivable $1.36M.
| Period end | Grants Receivable |
|---|---|
| 2025-06-30 | $50.00K 10-Q · filed 2025-08-08 |
| 2025-03-31 | $50.00K 10-Q · filed 2025-05-14 |
| 2024-06-30 | $181.00K 10-Q · filed 2024-08-13 |
| 2023-12-31 | $1.36M 10-K · filed 2025-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |